Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.25 and traded as low as $4.00. Evotec shares last traded at $4.04, with a volume of 48,150 shares.
Evotec Price Performance
The company has a market cap of $1.36 billion, a P/E ratio of 10.02 and a beta of 0.98. The company’s 50-day moving average price is $4.62 and its two-hundred day moving average price is $4.24. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- High Flyers: 3 Natural Gas Stocks for March 2022
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Oilfield Leader SLB: An AI Name You Need to Know
- The 3 Best Blue-Chip Stocks to Buy Now
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
